Daniela Wesch Selected Research

Daniela Wesch Research Topics

Disease

42	Neoplasms (Cancer) 01/2022 - 01/2003
11	Adenocarcinoma 01/2020 - 12/2004
4	Infections 01/2020 - 01/2003
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2018
3	Carcinogenesis 12/2019 - 03/2015
3	Pancreatic Neoplasms (Pancreatic Cancer) 03/2015 - 03/2014
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 03/2018
2	Inflammation (Inflammations) 12/2019 - 01/2003
2	Leukemia 01/2019 - 01/2007
2	Lymphoma (Lymphomas) 01/2019 - 01/2007
2	Hypersensitivity (Allergy) 11/2016 - 06/2011
2	Respiratory Insufficiency (Respiratory Failure) 06/2014 - 11/2012
2	Lung Injury 06/2014 - 08/2012
2	Acute Lung Injury 11/2012 - 08/2012
1	Bites and Stings (Sting) 01/2022
1	Obesity 05/2021
1	Type 2 Diabetes Mellitus (MODY) 05/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Glioma (Gliomas) 04/2016
1	Neoplasm Metastasis (Metastasis) 03/2015
1	Pneumonia (Pneumonitis) 06/2014
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2014

Drug/Important Bio-Agent (IBA)

13	LigandsIBA 01/2022 - 01/2007
7	AntigensIBA 01/2022 - 01/2014
7	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018 - 01/2007
5	CytokinesIBA 01/2022 - 07/2009
5	Bispecific AntibodiesIBA 01/2020 - 01/2014
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 11/2016
3	Carrier Proteins (Binding Protein)IBA 01/2022 - 04/2016
3	Diphosphates (Pyrophosphates)IBA 01/2021 - 03/2013
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 03/2014
3	DisintegrinsIBA 03/2018 - 10/2013
3	Metalloproteases (Metalloproteinases)IBA 03/2018 - 10/2013
3	Surface-Active Agents (Surfactants)IBA 06/2014 - 08/2012
3	LipopolysaccharidesIBA 06/2014 - 01/2010
2	human ERBB2 proteinIBA 01/2022 - 01/2018
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 11/2009
2	PlatinumIBA 01/2020 - 03/2018
2	Granzymes (Granzyme)IBA 01/2019 - 11/2009
2	Monoclonal AntibodiesIBA 01/2018 - 07/2009
2	Trastuzumab (Herceptin)FDA Link 01/2018 - 11/2016
2	Surface Antigens (Surface Antigen)IBA 01/2018 - 03/2013
2	NK Cell Lectin-Like Receptor Subfamily KIBA 01/2017 - 04/2016
2	diphosphoric acid (pyrophosphoric acid)IBA 11/2016 - 01/2010
2	micaIBA 04/2016 - 10/2013
2	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 07/2014 - 01/2014
2	EnzymesIBA 10/2013 - 08/2012
2	AcidsIBA 11/2012 - 08/2012
2	CeramidesIBA 11/2012 - 08/2012
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 11/2012 - 08/2012
2	Proteins (Proteins, Gene)FDA Link 01/2007 - 04/2006
1	AntibodiesIBA 01/2022
1	InterferonsIBA 01/2022
1	Biological ProductsIBA 01/2022
1	Zoledronic Acid (Zometa)FDA Link 01/2022
1	Blood Glucose (Blood Sugar)IBA 05/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Cetuximab (Erbitux)FDA Link 01/2021
1	Fc Receptors (Fc Receptor)IBA 01/2021
1	Natural Killer Cell ReceptorsIBA 01/2021
1	Galectins (Galectin)IBA 11/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 11/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020
1	KynurenineIBA 01/2020
1	resiquimodIBA 01/2020
1	Galectin 3 (LGALS3)IBA 01/2020
1	ChitosanIBA 01/2020
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 12/2019
1	PerforinIBA 01/2019
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2019
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 03/2018
1	AmphiregulinIBA 03/2018
1	Immunoglobulin Fab FragmentsIBA 01/2018
1	pertuzumabIBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 11/2017
1	SteroidsIBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2017
1	Interleukin-9 (Interleukin 9)IBA 11/2016
1	Temozolomide (Temodar)FDA LinkGeneric 04/2016
1	Diphosphonates (Bisphosphonates)IBA 07/2015
1	NitrogenIBA 07/2015
1	Ligases (Synthetase)IBA 03/2015
1	ProstaglandinsIBA 03/2015
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2015
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2015
1	Secretory Phospholipases A2IBA 06/2014
1	PhosphatidylglycerolsIBA 06/2014
1	1,2- dioleoyl- sn- glycero- 3- phosphoglycerol (DOPG)IBA 06/2014

Therapy/Procedure

20	Immunotherapy 01/2022 - 12/2004
7	Therapeutics 01/2022 - 12/2004
2	Drug Therapy (Chemotherapy) 03/2018 - 01/2014
2	Artificial Respiration (Mechanical Ventilation) 06/2014 - 11/2012
1	Resistance Training 03/2018
1	Adjuvant Chemotherapy 03/2018
1	Chemoradiotherapy 01/2017